Literature DB >> 11410395

Application of two-dimensional CSI for absolute quantification of phosphorus metabolites in the human liver.

Z Tosner1, M Dezortová, J Tintĕra, M Hájek.   

Abstract

There have recently been a number of studies dealing with the absolute quantification of concentrations of MR-visible phosphorus compounds in different tissues. The use of absolute values rather than intensity ratios may furnish additional information about metabolic changes associated with different diseases. The purpose of this study was to develop a general procedure for measuring molar metabolite concentrations and to apply it with respect to the evaluation of human liver 31P-MRS data measured using a standard slice-selective two-dimensional CSI sequence and commercial 1H/31P surface coil. The experimental determination of all surface coil-related factors influencing signal intensity was undertaken using a gradient echo imaging technique that can be adapted to commercial systems. The resulting values for healthy volunteers (N = 9) showed concentrations of PME = 2.8 +/- 1.3 mM, PDE = 9.9 +/- 2.7 mM, P(i) = 1.7+/-0.7 mM, and ATP = 3.6 +/- 0.9 mM in the human liver. The data are quite consistent with published findings.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410395     DOI: 10.1007/BF02668649

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  8 in total

1.  Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B1 inhomogeneity.

Authors:  J Murphy-Boesch; H Jiang; R Stoyanova; T R Brown
Journal:  Magn Reson Med       Date:  1998-03       Impact factor: 4.668

2.  Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions.

Authors:  P E Sijens; P C Dagnelie; S Halfwerk; P van Dijk; K Wicklow; M Oudkerk
Journal:  Magn Reson Imaging       Date:  1998       Impact factor: 2.546

3.  Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.

Authors:  C W Li; W G Negendank; J Murphy-Boesch; K Padavic-Shaller; T R Brown
Journal:  NMR Biomed       Date:  1996-06       Impact factor: 4.044

4.  Use of computer simulations for quantitation of 31P ISIS MRS results.

Authors:  G B Matson; D J Meyerhoff; T J Lawry; R S Lara; J Duijn; R F Deicken; M W Weiner
Journal:  NMR Biomed       Date:  1993 May-Jun       Impact factor: 4.044

5.  Quantitative P-31 MR spectroscopy of the liver in alcoholic cirrhosis.

Authors:  V Rajanayagam; R R Lee; Z Ackerman; W G Bradley; B D Ross
Journal:  J Magn Reson Imaging       Date:  1992 Mar-Apr       Impact factor: 4.813

6.  Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part II: Muscle, liver, kidney.

Authors:  R Buchli; D Meier; E Martin; P Boesiger
Journal:  Magn Reson Med       Date:  1994-10       Impact factor: 4.668

7.  Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans.

Authors:  R Löffler; R Sauter; H Kolem; A Haase; M von Kienlin
Journal:  J Magn Reson       Date:  1998-10       Impact factor: 2.229

8.  Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy.

Authors:  D J Meyerhoff; M D Boska; A M Thomas; M W Weiner
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

  8 in total
  7 in total

1.  Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.

Authors:  Monika Dezortova; Pavel Taimr; Antonin Skoch; Julius Spicak; Milan Hajek
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 2.  Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.

Authors:  Z Yuan; W-T Li; X-D Ye; H-Y Zhu; W-J Peng
Journal:  Clin Transl Oncol       Date:  2013-12-20       Impact factor: 3.405

3.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

Review 4.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

5.  Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.

Authors:  Adil Bashir; Robert Gropler; Joseph Ackerman
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

6.  Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using 31 P MRSI and Hepatic Lipid Volume Correction at 7T Suggests No Dependence on Body Mass Index or Age.

Authors:  Lorenz Pfleger; Martin Gajdošík; Peter Wolf; Sabina Smajis; Paul Fellinger; Andre Kuehne; Patrik Krumpolec; Siegfried Trattnig; Yvonne Winhofer; Michael Krebs; Martin Krššák; Marek Chmelík
Journal:  J Magn Reson Imaging       Date:  2018-10-06       Impact factor: 4.813

7.  In Vitro 31P MR Chemical Shifts of In Vivo-Detectable Metabolites at 3T as a Basis Set for a Pilot Evaluation of Skeletal Muscle and Liver 31P Spectra with LCModel Software.

Authors:  Petr Sedivy; Tereza Dusilova; Milan Hajek; Martin Burian; Martin Krššák; Monika Dezortova
Journal:  Molecules       Date:  2021-12-14       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.